Bispecific antibodies targeting BCMA, GPRC5D, and FcRH5 for multiple myeloma therapy: latest updates from ASCO 2023 Annual Meeting
- Resource Type
- article
- Source
- Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-4 (2023)
- Subject
Multiple myeloma Bispecific antibody BCMA GPRC5D FcRH5 Diseases of the blood and blood-forming organs RC633-647.5 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 - Language
- English
- ISSN
- 1756-8722